Pharmaceutical companies have an ethical responsibility to make their new treatments for diabetes and obesity available for anyone in need, in any country. The studys authors searched national drug price databases and collected information on six medications: orlistat, naltrexone/bupropion, topiramate/phentermine, liraglutide, semaglutide, and tirzepatide across a range of 16 low-, middle- and high-income countries
It sounds like its in everyones best interest to nurse that baby and then make further decisions about your healthcare
Belgium issued a new law in November banning doctors from prescribing Ozempic and other GLP-1 drugs for weight loss unless a patients BMI is 35 or above and has one underlying health condition
How you use that tool matters
At 5mg weekly, the same vial covers two weeks
The condition sneaks up on patients, often with subtle early symptoms that can be easily mistaken for the common fatigue of everyday life